Andreas Vogt
Impact in
- Toxicology top 1%
- Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling
- Protein Tyrosine Phosphatases
- Ubiquitin and proteasome pathways
- RNA and protein synthesis mechanisms
Papers in
-
- Protein Tyrosine Phosphatases 19
- Protein Kinase Regulation and GTPase Signaling 14
- Ubiquitin and proteasome pathways 10
- Oncology 30
- Cancer-related Molecular Pathways 8
- Peptidase Inhibition and Analysis 8
- Cancer Treatment and Pharmacology 7
- Co-authors
- John S. Lazo (27 shared papers)Andrew D. Hamilton (14 shared papers)Yimin Qian (12 shared papers)Saı̈d M. Sebti (6 shared papers)Billy W. Day (21 shared papers)Peter Wipf (21 shared papers)Saı̈d Sebti (8 shared papers)Jiazhi Sun (4 shared papers)
- Journals
- Journal of Biological Chemistry (7 papers)SLAS DISCOVERY (6 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)Bioorganic & Medicinal Chemistry (5 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Andreas Vogt
113 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 155
- Toxicology 172
- Molecular Biology 3.1k
- Cell Biology 724
- Oncology 1.0k
- Organic Chemistry 746
Countries citing papers authored by Andreas Vogt
This map shows the geographic impact of Andreas Vogt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Vogt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Vogt more than expected).
Fields of papers citing papers by Andreas Vogt
This network shows the impact of papers produced by Andreas Vogt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Vogt. The network helps show where Andreas Vogt may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Vogt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 314 | |
| 2 | 2009 | 203 | |
| 3 | 2001 | 169 | |
| 4 | 2005 | 160 | |
| 5 | 1997 | 160 | |
| 6 | 2013 | 153 | |
| 7 | Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. | 1996 | 139 |
| 8 | 2014 | 138 | |
| 9 | 2013 | 134 | |
| 10 | 1996 | 108 | |
| 11 | 2012 | 108 | |
| 12 | 2009 | 106 | |
| 13 | 2008 | 105 | |
| 14 | 1995 | 95 | |
| 15 | 2011 | 87 | |
| 16 | 2009 | 86 | |
| 17 | 2004 | 82 | |
| 18 | 2011 | 81 | |
| 19 | 2005 | 79 | |
| 20 | 2012 | 69 |
About Andreas Vogt
Andreas Vogt is a scholar working on Molecular Biology, Oncology, Cell Biology, Organic Chemistry and Pharmacology, having authored 115 papers that have together received 4.8k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (19 papers), Protein Kinase Regulation and GTPase Signaling (14 papers), Ubiquitin and proteasome pathways (10 papers), Zebrafish Biomedical Research Applications (8 papers), Cancer-related Molecular Pathways (8 papers), Peptidase Inhibition and Analysis (8 papers), Cancer Treatment and Pharmacology (7 papers) and Microbial Natural Products and Biosynthesis (7 papers). The work is most often cited by research in Toxicology (172 citations), Molecular Biology (3.1k citations), Cell Biology (724 citations), Oncology (1.0k citations) and Organic Chemistry (746 citations). Andreas Vogt has collaborated with scholars based in United States, Germany and China. Frequent co-authors include John S. Lazo, Andrew D. Hamilton, Yimin Qian, Saı̈d M. Sebti, Billy W. Day, Peter Wipf, Saı̈d Sebti, Jiazhi Sun, Michelle A. Blaskovich and Michael Tsang. Their work appears in journals such as Journal of Biological Chemistry, SLAS DISCOVERY, Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.